Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacologic ascorbate resistant pancreatic cancer demonstrates enhanced metastatic potential

Redox Biology(2025)10.1016/j.redox.2025.103694Source: DataRank Database

Pharmacologic ascorbate resistant pancreatic cancer demonstrates enhanced metastatic potential is a research paper published in Redox Biology (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

cellosaurus doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 2.31)OA: goldTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Brianne R. O’Leary ORCID,Juan Du ORCID,Garry R. Buettner ORCID,Michael D. Henry ORCID,Joseph J. Cullen ORCID

Live enrichment

PubMed:40440794 PMC:PMC12158610 OpenAlex:https://openalex.org/W4410590901

National Institutes of Health

Grant: P01 217797

National Institutes of Health

Grant: P1 217797

National Institutes of Health

Grant: R01 CA263550

National Institutes of Health

Grant: T32 CA78586

NIEHS NIH HHS

Grant: P30 ES005605

NCI NIH HHS

Grant: P01 CA217797

NCI NIH HHS

Grant: T32 CA078586

University of Iowa Roy J and Lucille A Carver College of Medicine

University of Iowa

FWCI

2.31

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.redox.2025.103694

publisherhttps://doi.org/10.1016/j.redox.2025.103694

publisherhttps://api.elsevier.com/content/article/PII:S2213231725002071?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213231725002071?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40440794

Fields of Study

Vitamin C and Antioxidants ResearchNanoparticles: synthesis and applicationsVitamin D Research StudiesHumansPancreatic NeoplasmsAscorbic AcidCell Line, TumorDrug Resistance, NeoplasmAnimalsMiceHydrogen PeroxideNeoplasm MetastasisEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticOxidation-ReductionXenograft Model Antitumor Assays

MeSH Terms

AnimalsAscorbic AcidHumansHydrogen PeroxideNeoplasm MetastasisOxidation-ReductionPancreatic NeoplasmsGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmXenograft Model Antitumor AssaysCell Line, TumorMiceEpithelial-Mesenchymal Transition

Keywords

Pancreatic cancerCancer researchMedicineCancerMetastasisInternal medicineOncologyBiologyAscorbateOxidative Stress And Metabolism

Sustainable Development Goals

SDG 0: Good health and well-being

Pharmacologic ascorbate resistant pancreatic cancer demonstrates enhanced metastatic potential

FAIR Checklist

Authors (6)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)